Non-aqueous taxane nanodispersion formulations and methods of using the same
AssigneeTeikoku Pharma USA, Inc.
InventorKiichiro Nabeta
Life of this patent
Estimating the term…
Loading patent…
AssigneeTeikoku Pharma USA, Inc.
InventorKiichiro Nabeta
Estimating the term…
Non-aqueous, ethanol-free taxane nanodispersion formulations are provided. Nanodispersion formulations of embodiments of the invention include a taxane, an oil, a non-ionic surfactant, a non-aqueous solvent, and an organic acid component, wherein the organic acid component is soluble in the non-aqueous solvent and the amount by weight of non-ionic surfactant is equal to or greater than the amount by weight of non-aqueous solvent. Also provided are methods of using the nanodispersion formulations, as well as kits that include the nanodispersion formulations. Non-aqueous, ethanol-free docetaxel nanodispersion formulations are provided. Nanodispersion formulations of embodiments of the invention include docetaxel, an oil, a non-ionic surfactant, a non-aqueous solvent, and an organic acid which is soluble in the non-aqueous solvent and is substantially free of any conjugate base. Also provided are methods of using the nanodispersion formulations, as well as kits that include the nanodispersion formulations.
A non-aqueous, ethanol-free taxane liquid nanodispersion formulation comprising:
A non-aqueous, ethanol-free docetaxel liquid nanodispersion formulation comprising:
A non-aqueous, ethanol-free docetaxel liquid nanodispersion formulation comprising:
A method of administering an ethanol-free taxane liquid nanodispersion formulation to a subject, the method comprising:
Dependencies are inferred from the claim text.